Harmful effects of NSAIDs among patients with hypertension and coronary artery disease - Wikidata - wikimedia - TriplyDB

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

http://www.wikidata.org/entity/Q36332332

about

NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species Clinical Pharmacology and Cardiovascular Safety of Naproxen Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects.Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications.Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiative Sedentary behavior and blood pressure control among osteoarthritis initiative participants.Relative cardiovascular and gastrointestinal safety of non-selective non-steroidal anti-inflammatory drugs versus cyclo-oxygenase-2 inhibitors: implications for clinical practice.Vertebral compression fractures: a review of current management and multimodal therapy.The relation between total joint arthroplasty and risk for serious cardiovascular events in patients with moderate-severe osteoarthritis: propensity score matched landmark analysis.Risk of stroke associated with nonsteroidal anti-inflammatory drugs 5-Lipoxygenase metabolic contributions to NSAID-induced organ toxicity.Non-steroidal anti-inflammatory drugs and hypertension.Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC.Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects.Influence of celecoxib on the vasodilating properties of human mesenteric arteries constricted with endothelin-1.Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease.Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients.Evaluation of Bloodletting Cupping Therapy in the Management of Hypertension.Analgesic Effect of 5-(3,4-Dihydroxyphenyl)-3-hydroxy-1-(2-hydroxyphenyl)penta-2,4-dien-1-one in Experimental Animal Models of Nociception

P2860

Q26784322-13C113E3-E556-43B3-AB47-2D668956C762 Q30360728-B6DE47BB-B180-428F-8A3D-AEAF2BFC41FF Q30425495-860BF3AF-515C-43D3-97F3-5CFDDF1B112D Q33757082-1580806A-876A-42E0-B06B-D72A4F511BFE Q34117657-D43A4859-7BA9-4BED-96E2-CF421EFEDC3B Q34156412-AE554D80-4236-4A90-B91D-AB5A80798220 Q34556831-BCC5ABFF-5B10-4EE8-9DBB-5442C76658F1 Q36957960-CF452534-38AD-4981-BD8E-BE2B59312003 Q37268786-282FCFF6-3A44-4685-8294-F9F51A3FE0AA Q37464386-831F985E-D2D2-419C-929A-085D969E1ACD Q37986694-5530112D-4FCF-42AB-A119-F9FD617677A7 Q38163403-233D4CDA-91C2-471C-A7A6-F779B4DA5CB1 Q38164425-DF5D2EF0-1EBF-4938-ACBC-7D4D44560ABD Q38243967-CC9D7104-53F8-4E6C-911E-2BA0B8B6C181 Q38807215-6AC9261D-0BE5-4F46-A68D-22A117F9FA62 Q38962092-CD6B22D8-1DFF-4497-B34B-2E9B002832BA Q38990657-81940DE8-0EC8-4E46-8679-70665B624FD5 Q48237956-A1F5F96E-3191-428D-BC4E-541EF76327FF Q55292216-803115A3-E07D-45F5-B8DB-7F7287EAB53D Q58696109-4BCCEC4A-0877-4353-A654-8E5FF7CD8F0C

P2860

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

http://www.wikidata.org/entity/Q36332332

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

@ast

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

@en

type

label

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

@ast

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

@en

prefLabel

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

@ast

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

@en

P1433

Q36332332-18C44FEA-F4E7-46EF-89B7-27E81925948D

P1476

Q36332332-FE006963-7916-4E64-84E8-67F0554D68E9

P2093

Q36332332-107AE36F-502F-4193-A266-32D01C840B61

Q36332332-85198CAD-C2F4-4738-B22B-E9B2F5B8A635

Q36332332-8EA94646-6BD6-4E58-BFEC-315A60CEF2CA

Q36332332-A420F7FE-1482-45D9-B0AE-020D45EEC462

Q36332332-C029C713-1030-48A1-9E1E-7E8F562346E4

Q36332332-E5DC1E16-FC0B-4E07-B0EF-CBF20227CB1C

P2860

Q36332332-22D8352F-5569-4C12-A9B0-BEF1BB36A936

Q36332332-2D6FABB1-6671-4EAA-BBEE-76C54CB73887

Q36332332-3018E122-F075-4DBC-8A19-A62FABB36371

Q36332332-34A59608-B7AA-4B0A-B7D0-3EA37D9967FF

Q36332332-40E202C1-47C0-4B7A-9FAF-902F5860BDCD

Q36332332-45640866-72D0-4E55-9D84-C8B1037E1838

Q36332332-46E8C501-53A8-4DFD-964A-721C9BF5AE56

Q36332332-48CBEFB9-F180-467D-9DE0-40D9CE3B9667

Q36332332-4B553FFE-1797-495D-B9B2-66EAB0D31CAA

Q36332332-5DA379F1-5194-4386-B1ED-DF034566FD1F

P304

Q36332332-C7FD4311-A454-4A62-8867-FEAEEFAEDEEE

P31

Q36332332-7CBEE77C-C328-416F-974E-38330FA53ED5

P356

Q36332332-C812A001-3EEF-4078-9E8B-AD4CD330A9C8

P407

Q36332332-92CE814F-368B-4F8E-9C14-9B3F76CB6ED5

P433

Q36332332-9BE6EC94-1C0F-4B43-98A3-9758540EC443

P478

Q36332332-BF82F30E-B171-44AD-A671-C17B9EC7793C

P577

Q36332332-5AB7997B-F9D5-4E7E-9B39-451B4EF7EC35

P5875

Q36332332-CCD2BB73-EA99-4DC4-BB35-658FF80E0273

P698

Q36332332-A9C3E535-001E-4D0A-BB84-5EDAF48E30A5

P921

Q36332332-66739D01-2E98-4038-800E-85F8ADB830C5

P932

Q36332332-C78145B7-B0E2-4B4A-8AE6-ED2737791D0F

P356

J.AMJMED.2011.02.025

P1433

The American Journal of Medicine

P1476

Harmful effects of NSAIDs among patients with hypertension and coronary artery disease

@en

P2093

Anthony A Bavry

http://www.w3.org/2001/XMLSchema#string

Asma Khaliq

http://www.w3.org/2001/XMLSchema#string

Carl J Pepine

http://www.w3.org/2001/XMLSchema#string

Eileen M Handberg

http://www.w3.org/2001/XMLSchema#string

Rhonda M Cooper-Dehoff

http://www.w3.org/2001/XMLSchema#string

Yan Gong

http://www.w3.org/2001/XMLSchema#string

P2860

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

Effect of ibuprofen on cardioprotective effect of aspirin

Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs

P304

614-620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJMED.2011.02.025

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51150224

http://www.w3.org/2001/XMLSchema#string

P698

21596367

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

4664475

http://www.w3.org/2001/XMLSchema#string